Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Center, Randomized, Double Blind, Saline Controlled Study of a Single Injection of Durolane® Versus a Single Injection of Phosphate Buffered Saline (PBS) to Treat Pain Associated With Osteoarthritis of the Knee

NCT01753830 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT01753830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01753830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Center, Randomized, Double Blind, Saline Controlled Study of a Single Injection of Durolane® Versus a Single Injection of Phosphate Buffered Saline (PBS) to Treat Pain Associated With Osteoarthritis of the Knee
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Terminated
Start date
December 31, 2012
Completion date
February 28, 2014
Enrollment
75 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis